| Analysis | Metabolite Name | Measured Value | Units | GROUP_ID |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.4933 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.4933 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.5862 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.7398 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.8392 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 0.9306 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.7505 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 1.7642 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 3.8998 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 4.1095 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | 1-palmitoyl-GPA (16:0) | 11.6748 | Relative Abundance | GOS |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|